We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+3.03%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$53B
AUM Growth
+$2.74B
(+5.4%)
Cap. Flow
+$1.72B
Cap. Flow
% of AUM
3.25%
Top 10 Holdings %
Top 10 Hldgs %
12.11%
Holding
2,575
New
173
Increased
1,093
Reduced
1,142
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Utilities AlphaDEX Fund
FXU
|
+$578M |
| 2 |
Lumen
LUMN
|
+$153M |
| 3 |
Arista Networks
ANET
|
+$110M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$107M |
| 5 |
Wells Fargo
WFC
|
+$99.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$511M |
| 2 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$146M |
| 3 |
Open Text
OTEX
|
+$102M |
| 4 |
Equinix
EQIX
|
+$91.4M |
| 5 |
Pfizer
PFE
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.18% |
| 2 | Healthcare | 12.51% |
| 3 | Communication Services | 10.75% |
| 4 | Financials | 10.66% |
| 5 | Consumer Discretionary | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FBZ
101
DELISTED
First Trust Brazil AlphaDEX Fund
FBZ
| $113M | 0.21% |
7,163,217
-704,355
| -9% | -$10.3M |
|
102
Acadia Pharmaceuticals
ACAD
$4.25B
| $113M | 0.21% |
4,219,069
-596,707
| -12% | -$15.2M |
|
|
SPLK
103
DELISTED
Splunk Inc
SPLK
| $112M | 0.21% |
890,373
+157,153
| +21% | +$20M |
|
|
104
Pfizer
PFE
$140B
| $111M | 0.21% |
2,698,837
-2,249,247
| -45% | -$89.3M |
|
105
First Trust Switzerland AlphaDEX Fund
FSZ
$36M
| $110M | 0.21% |
2,146,010
-211,021
| -9% | -$10.5M |
|
106
Gen Digital
GEN
$15.4B
| $109M | 0.21% |
5,020,188
-1,307,514
| -21% | -$28.1M |
|
107
Regeneron Pharmaceuticals
REGN
$69.6B
| $109M | 0.2% |
346,960
-13,602
| -4% | -$4.53M |
|
108
Ionis Pharmaceuticals
IONS
$9.36B
| $109M | 0.2% |
1,688,275
-903,564
| -35% | -$63.9M |
|
109
Eli Lilly
LLY
$1.07T
| $108M | 0.2% |
975,350
+226,281
| +30% | +$26.6M |
|
110
Neurocrine Biosciences
NBIX
$17.6B
| $108M | 0.2% |
1,277,700
+194,643
| +18% | +$16M |
|
|
BLUE
111
DELISTED
bluebird bio
BLUE
| $107M | 0.2% |
65,012
+6,085
| +10% | +$10.5M |
|
|
GRFS
112
Grifois
GRFS
$5.16B
| $107M | 0.2% |
5,073,910
-51,809
| -1% | -$988K |
|
113
BioMarin Pharmaceuticals
BMRN
$11.4B
| $107M | 0.2% |
1,249,061
-12,847
| -1% | -$1.1M |
|
114
Nektar Therapeutics
NKTR
$2.37B
| $107M | 0.2% |
200,400
+57,121
| +40% | +$28.6M |
|
115
Southern Company
SO
$110B
| $106M | 0.2% |
1,920,115
+367,221
| +24% | +$19.7M |
|
|
BICK
116
DELISTED
First Trust BICK Index Fund
BICK
| $106M | 0.2% |
3,926,094
-386,082
| -9% | -$10.3M |
|
117
Omnicom Group
OMC
$22.6B
| $104M | 0.2% |
1,271,586
+31,965
| +3% | +$2.52M |
|
118
Exelon
EXC
$48.6B
| $104M | 0.2% |
3,046,990
+1,531,222
| +101% | +$54M |
|
119
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.28B
| $104M | 0.2% |
1,925,656
-188,384
| -9% | -$10.1M |
|
120
Autodesk
ADSK
$44B
| $103M | 0.19% |
631,398
-47,406
| -7% | -$7.97M |
|
121
Thermo Fisher Scientific
TMO
$210B
| $102M | 0.19% |
348,903
-81,326
| -19% | -$22.4M |
|
122
Procter & Gamble
PG
$342B
| $101M | 0.19% |
923,772
-597,315
| -39% | -$63.7M |
|
123
Check Point Software Technologies
CHKP
$13B
| $101M | 0.19% |
872,515
-147,461
| -14% | -$17.4M |
|
124
Qiagen
QGEN
$8.53B
| $101M | 0.19% |
2,343,102
-189,134
| -7% | -$7.84M |
|
125
First Trust Germany AlphaDEX Fund
FGM
$95.7M
| $101M | 0.19% |
2,406,303
-236,576
| -9% | -$9.99M |
|
Similar funds
DAM
First Trust Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, First Trust Advisors held 2,575 positions worth $53B, up 5.4% from $50.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
First Trust Advisors deployed $1.72B of net new capital in Q2 2019, opening 173 new positions and adding to 1,093 existing holdings. Its largest new stake was First Trust Utilities AlphaDEX Fund: 20,307,209 shares worth $583M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was ZYNGA INC. CL A COMMON, an estimated $146M trimmed.
- First Trust Advisors's largest Q2 2019 buy was First Trust Utilities AlphaDEX Fund: 20,307,209 shares worth $583M.
- First Trust Advisors added most to Lumen in Q2 2019, an estimated $153M increase.
- First Trust Advisors's biggest Q2 2019 reduction was ZYNGA INC. CL A COMMON, cutting an estimated $146M.
- First Trust Advisors fully exited First Trust Health Care AlphaDEX Fund in Q2 2019, selling an estimated $511M.
- First Trust Advisors's ten largest holdings make up 12% of its $53B portfolio in Q2 2019.
- First Trust Advisors opened 173 new positions and closed 163 in Q2 2019.
- First Trust Advisors's portfolio value rose 5.4% quarter-over-quarter to $53B.
Based on First Trust Advisors's 13F filing for Q2 2019, filed 30 Jul 2019.